Close

UPDATE: Citi Upgrades Royalty Pharma (RPRX) to Buy

October 29, 2021 6:29 AM EDT Send to a Friend
(Updated - October 29, 2021 7:05 AM EDT)

Citi analyst Andrew Baum upgraded Royalty Pharma (NASDAQ: RPRX) from Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login